Conducting preclinical research is a pivotal phase in drug development, setting the foundation for safe and effective therapies. For companies in or around Durham seeking top-tier preclinical contract research organization (CRO) services, InfinixBio stands at the forefront, offering tailored solutions that streamline the path from discovery to market.
A preclinical CRO specializes in conducting research and analysis to support drug development before clinical trials begin. This involves a wide array of services including assay development, genetic engineering, and pharmacokinetic studies. InfinixBio’s commitment to scientific rigor ensures that clients receive reliable data that inform their decisions in the drug development lifecycle.
Preclinical studies are essential for:
At InfinixBio, our full-service capabilities encompass various stages of preclinical research tailored to meet the unique needs of our clients. Here are some key services we provide:
Our experts design and validate assays to accurately evaluate drug candidates’ properties and performance.
We provide in-depth analysis of drug absorption, distribution, metabolism, and excretion, crucial for understanding how drugs behave in the body.
InfinixBio supports clients in the preparation of Investigational New Drug (IND) applications, providing comprehensive research data needed for regulatory submissions.
Through advanced testing services, we assess the immune response elicited by therapies, ensuring safety and efficacy.
We offer services that identify and validate biomarkers critical for patient stratification and treatment monitoring.
Choosing a partner like InfinixBio presents several strategic advantages:
Companies should evaluate the CRO’s expertise in their targeted therapeutic area, the range of services offered, previous client success stories, and the quality of their laboratory facilities.
By providing early insights through our comprehensive preclinical services, we help clients make informed decisions quickly, leading to faster progression through the drug development pipeline.
Engaging a CRO is optimal when companies lack the in-house resources or expertise required to carry out sophisticated research and development activities. Specific transitional phases may include before IND submissions or when entering new therapeutic areas.
Preclinical research is a fundamental aspect of drug development that can significantly affect the success of clinical trials. InfinixBio’s comprehensive preclinical CRO services in Durham are designed to help biopharmaceutical companies navigate this critical phase efficiently.
Contact us today to learn more about how we can support your preclinical research needs and accelerate your journey to market.
Our experienced lab team is here to help. Reach out today to learn more.